4.
    发明专利
    未知

    公开(公告)号:NO20063138L

    公开(公告)日:2006-09-06

    申请号:NO20063138

    申请日:2006-07-06

    Abstract: The invention relates to a group of hydronopol derivatives which are agonists on human ORL1 (nociceptin) receptors. The invention also relates to the preparation of these compounds, to pharmaceutical compositions containing a pharmacologically active amount of at least one of these novel hydronopol derivatives as an active ingredient, as well as to the use of these pharmaceutical compositions for the treatment of disorders in which ORL1 receptors are involved. The invention relates to compounds of the general formula (1) wherein the symbols have the meanings as given in the description.

    6.
    发明专利
    未知

    公开(公告)号:PT1176144E

    公开(公告)日:2003-11-28

    申请号:PT01117433

    申请日:2001-07-19

    Abstract: 1-(3,5-bis-(Trifluoromethyl)-benzoyl)-2-(1H-indol-3-ylmethyl)-4-((5-am inomethyl-2H-1,2,3-triazol-4-yl)-methyl)-piperazines (I) are new. Triazole derivatives of formula (I) and their acid addition salts are new. R1 = H or alkyl; R2 = alkyl; dialkylaminoalkyl, alkoxycarbonylalkyl; 5-6 membered cycloalkyl (or its heterocyclic analog) optionally substituted by 1 or 2 alkyl; phenylalkyl (or its heterocyclic analog), optionally substituted in the ring by 1 or 2 of halo, alkyl and/or alkoxy and optionally substituted in the alkyl chain by 1 or 2 of alkyl or spiro-4-5C alkylene; or phenylalkoxy, optionally substituted in the ring by 1 or 2 of halo, alkyl and/or alkoxy; R3 = alkyl; alkoxycarbonylalkyl; or 5-6 membered cycloalkyl (or its heterocyclic analog) optionally substituted by 1 or 2 alkyl; or NR2R3 = cyclic amino of formula (a); or a pyrrolidine ring substituted by a 4C alkylene chain bonded to two adjacent C; A = N, O, CH2 or CH; n = 1-3; R4 = H, alkoxyalkyl, alkoxycarbonyl, alkoxycarbonylalkyl or dialkylaminoalkyl; phenylalkyl (or its heterocyclic analog), optionally substituted in the ring by 1 or 2 of halo, alkyl and/or alkoxy and optionally substituted in the alkyl chain by 1 or 2 alkyl; 5-6 membered cycloalkyl (or its heterocyclic analog); or 5-6 membered cycloalkyl-alkyl (or its heterocyclic analog) ; R5 = H, alkyl or alkoxyalkyl; or R4 + R5 = spiro-ethylenedioxy, 3-4C alkylene bonded to two adjacent C or a fused benzene ring; all alkyl moieties are lower, i.e. have 1-4C. Independent claims are included for: (i) the preparation of (I); and (ii) new azide intermediates of formula (IV).

    8.
    发明专利
    未知

    公开(公告)号:PT689837E

    公开(公告)日:2002-04-29

    申请号:PT95109812

    申请日:1995-06-23

    Abstract: The use of 4-chloro-5-((4,5-dihydro-1H-imidazol-2-yl)- amino)-6-methoxypyrimidine of formula (I) or its acid addn. salts is claimed for the prepn. of pharmaceutical compsns. for the treatment of hyperglycaemia. Also claimed in the prepn. of such as compsn. by converting an antihyperglycaemically active amt. of (I) or its salt into a suitable dosage form, in combination with conventional auxiliaries.

    DERIVATIVES OF N-TRIAZOLYLMETHYLPIPERAZINE AS NEUROKININE RECEPTOR-ANTAGONISTS, PREPARATION THEREOF AND MEDICAMENTS

    公开(公告)号:SK7572001A3

    公开(公告)日:2002-02-05

    申请号:SK7572001

    申请日:2001-06-01

    Abstract: 1-(3,5-bis-(Trifluoromethyl)-benzoyl)-2-(1H-indol-3-ylmethyl)-4-((5-am inomethyl-2H-1,2,3-triazol-4-yl)-methyl)-piperazines (I) are new. Triazole derivatives of formula (I) and their acid addition salts are new. R1 = H or alkyl; R2 = alkyl; dialkylaminoalkyl, alkoxycarbonylalkyl; 5-6 membered cycloalkyl (or its heterocyclic analog) optionally substituted by 1 or 2 alkyl; phenylalkyl (or its heterocyclic analog), optionally substituted in the ring by 1 or 2 of halo, alkyl and/or alkoxy and optionally substituted in the alkyl chain by 1 or 2 of alkyl or spiro-4-5C alkylene; or phenylalkoxy, optionally substituted in the ring by 1 or 2 of halo, alkyl and/or alkoxy; R3 = alkyl; alkoxycarbonylalkyl; or 5-6 membered cycloalkyl (or its heterocyclic analog) optionally substituted by 1 or 2 alkyl; or NR2R3 = cyclic amino of formula (a); or a pyrrolidine ring substituted by a 4C alkylene chain bonded to two adjacent C; A = N, O, CH2 or CH; n = 1-3; R4 = H, alkoxyalkyl, alkoxycarbonyl, alkoxycarbonylalkyl or dialkylaminoalkyl; phenylalkyl (or its heterocyclic analog), optionally substituted in the ring by 1 or 2 of halo, alkyl and/or alkoxy and optionally substituted in the alkyl chain by 1 or 2 alkyl; 5-6 membered cycloalkyl (or its heterocyclic analog); or 5-6 membered cycloalkyl-alkyl (or its heterocyclic analog) ; R5 = H, alkyl or alkoxyalkyl; or R4 + R5 = spiro-ethylenedioxy, 3-4C alkylene bonded to two adjacent C or a fused benzene ring; all alkyl moieties are lower, i.e. have 1-4C. Independent claims are included for: (i) the preparation of (I); and (ii) new azide intermediates of formula (IV).

    ANTI-HYPERGLYCEMIC MEDICAMENTS
    10.
    发明专利

    公开(公告)号:SK282227B6

    公开(公告)日:2001-12-03

    申请号:SK74995

    申请日:1995-06-06

    Abstract: The use of 4-chloro-5-((4,5-dihydro-1H-imidazol-2-yl)- amino)-6-methoxypyrimidine of formula (I) or its acid addn. salts is claimed for the prepn. of pharmaceutical compsns. for the treatment of hyperglycaemia. Also claimed in the prepn. of such as compsn. by converting an antihyperglycaemically active amt. of (I) or its salt into a suitable dosage form, in combination with conventional auxiliaries.

Patent Agency Ranking